One component of the antigen-induced contraction of the guinea-pig trachea is mediated by serotonin acting on 5-HT2A receptors Source: Eur Respir J 2007; 30: Suppl. 51, 620s Year: 2007
Immunohistochemical relationship between transient receptor potential vanilloid-1 (TRPV1) and neuropeptide (CGRP, Substance P) in the guinea pig respiratory system Source: Eur Respir J 2005; 26: Suppl. 49, 364s Year: 2005
Effect of AVE5883, a dual NK1/NK2 receptor antagonist, on airway responsiveness to neurokinin A in asthma Source: Eur Respir J 2004; 24: Suppl. 48, 219s Year: 2004
Increased relaxation of immature airways to beta-2 agonists is related to the attenuated expression of postjunctional smooth muscle muscarinic M2 receptors Source: Annual Congress 2004 - Understanding the complexity of how airways are regulated Year: 2004
EP2 & EP4 receptor agonists inhibit the airway sensory nerves that cause cough, a potential protective control that is lost in human smokers and a pre-clinical COPD model Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017
Mice lacking both M2 and M3 muscarinic receptors display airway hyperresponsiveness (AHR) to serotonin Source: Eur Respir J 2005; 26: Suppl. 49, 714s Year: 2005
Combined loss of M2 and M3 muscarinic acetylcholine receptor (mAChR) function in mutant mice increases serotonin airway responsiveness (AR) Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Pharmacological activities of R-113281, a triple NK1 /NK2 /NK3 neurokinin receptor antagonist Source: Eur Respir J 2001; 18: Suppl. 33, 264s Year: 2001
Insulin acutely potentiates M3 muscarinic receptor function in rat and human airway smooth muscle Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017
Muscarinic receptor dependent contraction of small airways from both rats and humans Source: Eur Respir J 2006; 28: Suppl. 50, 432s Year: 2006
Ethanol (EtOH) promotes Ca2+ mobilization and neuropeptide release from airway sensory nerves via vanilloid receptor 1 (VR1) activation Source: Eur Respir J 2002; 20: Suppl. 38, 170s Year: 2002
Potentiation effect of insulin on M3 muscarinic receptor agonist induced airway smooth muscle contraction Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019
CS-003, a novel triple neurokinin receptor antagonist, inhibits symptoms of respiratory diseases models in guinea pigs Source: Eur Respir J 2006; 28: Suppl. 50, 664s Year: 2006
Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005
EPAC drives the anti-tussive effect of EP4 receptors on airway sensory nerves Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020
Effects of a newly developed dual CysLT1 and CysLT2 receptor antagonist, ONO-RS-531, on antigen- and leukotriene D4 -induced contractions of isolated human bronchi Source: Eur Respir J 2005; 26: Suppl. 49, 214s Year: 2005
Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients Source: Eur Respir J 2004; 23: 76-81 Year: 2004
Neural mechanisms in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=138 Year: 2003
The cannabinoid receptor agonist, WIN 55,212-2, inhibits antigen-induced plasma extravasation in guinea pig airways Source: Annual Congress 2010 - Models of airways disease Year: 2010
Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010